Appropriate use of immune checkpoint inhibitors and immunotherapy differs in adults with unresectable, metastatic cutaneous ...

What is the work you’re leading at KaliVir as CEO? Our goal is to develop viral treatments that can reach and eliminate cancer cells in the body, bringing us closer to a cure for all cancer patients.

—Building off of earlier findings, researchers sought to determine rates of neoadjuvant systemic therapy (NST) among U.S. women with cT1–2 N0 M0 HER2-positive breast cancer and identify factors ...

Trials in Progress: The Power of Timely Cancer Clinical Trial Communication Gastric cancer (GC) and esophageal cancer (EC) are the fifth and seventh leading causes of cancer-related mortality globally ...

Dr. Van Morris presents the new evidence-based guideline on systemic therapy for localized anal squamous cell carcinoma. Dr. Morris discusses the key recommendations from the Expert Panel, including ...

Chimeric antigen receptor T (CAR-T) cell therapy has emerged as a transformative approach in modern medicine, demonstrating remarkable efficacy in targeting pathogenic B-cell lineages with ...